Vedolizumab for induction and maintenance of remission in ulcerative colitis: Cochrane systematic review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Vedolizumab for Induction and Maintenance of Remission in Ulcerative Colitis: Cochrane Systematic Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/437045/all/Vedolizumab_for_induction_and_maintenance_of_remission_in_ulcerative_colitis:_Cochrane_systematic_review. Accessed 09 October 2024.
Vedolizumab for induction and maintenance of remission in ulcerative colitis: Cochrane systematic review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437045/all/Vedolizumab_for_induction_and_maintenance_of_remission_in_ulcerative_colitis:_Cochrane_systematic_review. Accessed October 9, 2024.
Vedolizumab for induction and maintenance of remission in ulcerative colitis: Cochrane systematic review. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/437045/all/Vedolizumab_for_induction_and_maintenance_of_remission_in_ulcerative_colitis:_Cochrane_systematic_review
Vedolizumab for Induction and Maintenance of Remission in Ulcerative Colitis: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. [cited 2024 October 09]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/437045/all/Vedolizumab_for_induction_and_maintenance_of_remission_in_ulcerative_colitis:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Vedolizumab for induction and maintenance of remission in ulcerative colitis: Cochrane systematic review
ID - 437045
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/437045/all/Vedolizumab_for_induction_and_maintenance_of_remission_in_ulcerative_colitis:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -